Skip to main content
JEONJINBIO CO., LTD. logo

JEONJINBIO CO., LTD. — Investor Relations & Filings

Ticker · 110020 ISIN · KR7110020005 KO Manufacturing
Open in API
Filings indexed 371 across all filing types
Latest filing 2020-11-17 Major Shareholding Noti…
Country KR South Korea
Listing KO 110020

About JEONJINBIO CO., LTD.

http://jjbious.com/01

JEONJINBIO CO., LTD. is a biotechnology company specializing in the research, development, and production of products for pest control and the mitigation of damage from nuisance animals. The company's core offerings consist of natural bio-pesticides and repellents formulated from natural materials as alternatives to conventional chemical products. Its product line includes specialized solutions for repelling birds, boars, and other animals. The company emphasizes innovation and safety, supported by its dedicated research and development center and various product certifications, including USA EPA approval for its bird repellent.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a regulatory filing required under Article 147 of the Capital Markets Act in South Korea. This document details changes in share ownership by major shareholders and their special relations, including specific transaction dates, methods (e.g., acquisition, disposal, gift), and share counts. It does not fit into categories like 'Director's Dealing' (which is for individual insider trades) or 'Major Shareholding Notification' (which is a broader category, but this specific Korean regulatory form is best classified as a Regulatory Filing). Given the specific nature of the form and its regulatory purpose, it falls under the RNS category.
2020-11-17 Korean
분기보고서 (2020.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Jeonjin Bio Pharm Co., Ltd. for the period ending September 30, 2020. It contains detailed financial statements, management discussion and analysis, and corporate governance information, which are characteristic of a comprehensive interim financial report. It is not an announcement of a report, but the report itself. 9M 2020
2020-11-10 Korean
[기재정정]증권신고서(지분증권)
Capital/Financing Update Classification · 95% confidence The document is a 'Correction Report' (정정신고) for a Securities Registration Statement (증권신고서). It details specific amendments made to financial data, business risk disclosures, and sales figures following the submission of a quarterly report. It is a regulatory filing submitted to the financial authorities to update previously filed information, which falls under the category of Regulatory Filings.
2020-11-10 Korean
[기재정정]투자설명서
Investor Presentation Classification · 98% confidence The document is a 'Correction Report' (정정신고) for a 'Securities Registration Statement' (투자설명서), which is a regulatory filing required when there are material changes to previously submitted documents. It explicitly lists the history of submissions, including the original filing and subsequent amendments due to the submission of quarterly reports. This falls under the category of regulatory filings as it is a formal amendment to a prospectus/securities filing.
2020-11-10 Korean
[기재정정]사업보고서 (2019.12)
Annual Report Classification · 100% confidence The document is a 'Correction Report' (정정신고) for a previously filed 'Annual Report' (사업보고서) for the 16th fiscal year of Jeonjin Bio Pharm Co., Ltd. It explicitly details corrections made to financial statements, including the balance sheet, cash flow statement, and notes to financial statements (such as property, plant, and equipment). Since this is a formal amendment to an existing Annual Report containing substantive financial data, it is classified as an Annual Report (10-K). FY 2019
2020-11-09 Korean
[기재정정]분기보고서 (2020.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Jeonjin Bio Pharm Co., Ltd. It contains detailed financial statements, notes to the financial statements, and management analysis for the first quarter of 2020. Although it is labeled as a 'Correction Report' (정정신고), it functions as the primary quarterly financial disclosure document containing substantive financial data, which fits the definition of an Interim/Quarterly Report (IR). Q1 2020
2020-11-09 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.